2023

(9) Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein. Geng, Q., Wan, Y., Hsueh, F., Shang, J., Ye, G., Bu, F., Herbst, M., Wilkens, R., Liu, B., Li, F. eLife.  

(7) Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19. Ye G, Pan, R., Bu, F., Zheng, J., Mendoza, A., Wen, W., Du, L., Spiller, B., Wadzinski, B.E., Liu, B., Perlman, S., Li, F. J Virol. 

(6) Glycoproteomic landscape and structural dynamics of TIM family immune checkpoints enabled by mucinase SmE. Chongsaritsinsuk, J., Steigmeyer, A.D., Mahoney, K.E. et al. Nat Communications. 

(5) DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Jimmidi, R., Chamakuri, S., Lu, S. et al. Communications Chemistry. 

(4) SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx, Kim, S. H., et al., Cell Reports Physical Science. 

(3) Rapid resistance profiling of SARS-CoV-2 protease inhibitorsMoghadasi, S.A. et al., bioRxiv: the preprint server for biology. 

(2) Flavivirus nonstructural proteins and replication complexes as antiviral drug targets, Elsen, K., Chew, B., Ho, J., Luo, D. Current Opinion in Virology

(1)  SARS-CoV-2 3CLpro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376, Heilmann, E. et al., Science translational medicine. 

2022

(11) Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors, Moghadasi, S.A. et al., Science Advances. 

(10) Understanding Immune Responses to Lassa Virus Infection and to Its Candidate Vaccines, Murphy, H., & Ly, H., Vaccines. 

(9) SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3'-Deoxy-3', 4'-dihydro-cytidine Nucleotide from RNA. Moeller, N. H., Passow, K. T., Harki, D. A., & Aihara, H., Viruses. 

(8) Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants, Yang, Y., & Du, L., Cellular & molecular immunology.  

(7) Spike-heparan sulfate interactions in SARS-CoV-2 infection, Kearns, F. L., et al., Current opinion in structural biology. 

(6) Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant, Zhang, W. et al., Proceedings of the National Academy of Sciences

(5) SARS-CoV-2 nsp14 Exoribonuclease Removes the Natural Antiviral 3'-Deoxy-3',4'-didehydro-cytidine Nucleotide from RNA, Moeller, N.H. et al., Viruses 

(4) Gain-of-Signal Assays for Probing Inhibition of SARS-CoV-2 Mpro/3CLpro in Living Cells, Moghadasi, S.A. et al., mBio

(3) Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1, Geng, Q. et al., Journal of Virology

(2) Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN, Moeller, N.H. et al., Proceedings of the National Academy of Sciences

(1) Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain, Ye, G. et al., Nature Communications

2021

(4) Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection, Geng, Q. et al., PLOS Pathogens

(3) The Development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates, Ye, G. et al., eLife

(2) Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA, Dileepan, M. et al., Virulence

(1) Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium, Fiege, J. et al., PLOS Pathogens

2020

(5) Cell entry mechanisms of SARS-CoV-2, Shang, J. et al., Proceedings of the National Academy of Sciences

(4) Structural basis of receptor recognition by SARS-CoV-2, Shang, J. et al., Nature

(3) Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry, Shang, J. et al., PLOS Pathogens

(2) Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry, Wan, Y., et al., Journal of Virology

(1) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-Long structural studies of SARS coronavirus, Wan et al., Journal of Virology